A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum

Summary

A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase II Study to Evaluate the Efficacy, Tolerability, and Safety of Topical VBP-245 in Pediatric Subjects for the Treatment of Molluscum Contagiosum (VBP-245-MCV).

Timeline

Start

2017-02-27

Primary completion

2018-03-30

Completion

2018-04-27

Drugs

Indications